Thalidomide-NH-C8-NH2
Modify Date: 2024-01-16 19:28:46
Thalidomide-NH-C8-NH2 structure
|
Common Name | Thalidomide-NH-C8-NH2 | ||
|---|---|---|---|---|
| CAS Number | 1957236-36-0 | Molecular Weight | 400.47 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C21H28N4O4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Thalidomide-NH-C8-NH2Thalidomide-NH-C8-NH2 is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology[1]. |
| Name | Thalidomide-NH-C8-NH2 |
|---|
| Description | Thalidomide-NH-C8-NH2 is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology[1]. |
|---|---|
| Related Catalog | |
| Target |
Cereblon |
| In Vitro | PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[2]. |
| References |
| Molecular Formula | C21H28N4O4 |
|---|---|
| Molecular Weight | 400.47 |